Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMYMP) Other financing activities (2016 - 2022)

Historic Other financing activities for Bristol Myers Squibb (BMYMP) over the last 14 years, with Q4 2022 value amounting to $179.0 million.

  • Bristol Myers Squibb's Other financing activities rose 606666.67% to $179.0 million in Q4 2022 from the same period last year, while for Dec 2022 it was $984.0 million, marking a year-over-year increase of 5351.01%. This contributed to the annual value of $27.0 million for FY2023, which is 9725.61% down from last year.
  • Latest data reveals that Bristol Myers Squibb reported Other financing activities of $179.0 million as of Q4 2022, which was up 606666.67% from $53.0 million recorded in Q3 2022.
  • Bristol Myers Squibb's Other financing activities' 5-year high stood at $419.0 million during Q2 2022, with a 5-year trough of -$58.0 million in Q1 2018.
  • For the 5-year period, Bristol Myers Squibb's Other financing activities averaged around $103.0 million, with its median value being $35.5 million (2020).
  • Its Other financing activities has fluctuated over the past 5 years, first tumbled by 140000.0% in 2019, then soared by 1720000.0% in 2020.
  • Over the past 5 years, Bristol Myers Squibb's Other financing activities (Quarter) stood at $1.0 million in 2018, then tumbled by 1400.0% to -$13.0 million in 2019, then soared by 2230.77% to $277.0 million in 2020, then plummeted by 101.08% to -$3.0 million in 2021, then skyrocketed by 6066.67% to $179.0 million in 2022.
  • Its last three reported values are $179.0 million in Q4 2022, $53.0 million for Q3 2022, and $419.0 million during Q2 2022.